CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $1.43 per share versus the Zacks Consensus Estimate of a loss of$ 1.63. This compares to loss of $0.67 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 12.27%. A quarter ago, it was expected that this company would post a loss of$ 0.40 per share when it actually produced earnings of $1.10, delivering a surprise of 375%.Over the last four quarters, the company has s ...